Publication date: Aug 13, 2019
John M. Gray , Opinion contributor Published 6:46 p. m. CT Aug. 12, 2019 The prescription opioid abuse crisis is complex, but it can be addressed if we are honest about its causes: Opposing view As part of the national debate about the opioid epidemic and its causes, pharmaceutical wholesale distributors have been the subject of a variety of unfounded claims, most notably the myth that distributors could have unilaterally stemmed the crisis.
OUR VIEW: Drugmakers and distributors made and sold pills ‘like Doritos’ Distributors are committed to working collaboratively to reverse this epidemic, and the industry has endorsed a range of policy measures that will go a long way toward ensuring that opioid prescriptions are better tracked and managed.
The prescription opioid abuse crisis is complex, but it can be addressed if we are honest about its causes and work together to move beyond misleading rhetoric and misplaced blame and toward practical problem solving.
- 76 billion opioid pills: Newly released federal data unmasks the epidemic
- 5.6 billion opioid pills flooded the state, and rogue South Florida doctors helped get them on the streets
- Newly public data maps opioid crisis across U.S.
- Little-known makers of generic drugs played central role in opioid crisis, records show
- The DEA, Big Pharma and the opioid crisis
- More than a billion prescription opioid pills streamed into Colorado amid national crisis
- How the pharmaceutical companies, Congress and the DEA made the opioid epidemic a billion-dollar industry
- Federal data shows opioid shipments ballooned as crisis grew
- Litigation Over America’s Opioid Crisis Is Heating Up
- Preventing the Next Crisis: Six Critical Questions About the Opioid Epidemic That Need Answers
- Prestigious Consulting Firm McKinsey Thrust Into Spotlight Over Advice It Gave To Drugmakers At Height Of Opioid Crisis
- Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among Veterans.